Cyproheptadine Hydrochloride Tablet
Product Images NDC 70771-1076

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 70771-1076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (6565ce65 02ad 47a6 9188 3c6bcee34f18 02)

This is a description of a medication called Cyproheptadine Hydrochloride Tablets, USP with each tablet containing 4 mg of the drug. It is advised to refer to the package for usual dosage, prescribing information, and storage instructions. The drug should be stored at 20°C to 25°C (68°F to 77°F) and dispensed in a well-closed container as defined by the USP. The drug is manufactured by Cadila Healthcare Ltd. The rest of the text is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.